Ethics & Conflicts Of Interest In Phase 1 Trials

This session addresses the ethical challenges and conflicts of interest that arise in oncology trials, with a focus on Phase I studies. Key topics include the influence of financial losses on trial integrity, the ethical dilemmas posed by study cancellations, and solutions such as risk-based payment models and early termination policies. Attendees will gain insights into upholding ethical standards while navigating the financial and operational complexities of oncology research.

Speakers

April Coburn

Luke Gelinas

Dan Otap